📖 Approx. 11 min ／ Updated 2026.10.04
For executives running a medical corporation, future business succession is an inevitable and critical challenge. In particular, for medical corporations with equity interests (ownership shares), inheritance and gift taxes often present an immense burden during succession. One highly effective option to resolve this issue is transitioning to a “medical corporation without equity.” In this article, geared toward board presidents and clinic directors considering this transition, we provide an in-depth explanation from the expert perspective of medical M&A and business succession—covering advantages, disadvantages, complex tax treatments, and concrete steps for implementation. We hope this serves as a valuable resource for your long-term, seamless succession strategy.
What Is a Medical Corporation Without Equity? Overview and Background
Medical corporations in Japan are broadly classified into two categories based on their incorporation structure: “medical corporations with equity” (ownership shares) and “medical corporations without equity.” While equity-based medical corporations were historically the standard, the Medical Care Act revision in 2007 (Heisei 19) established that, in principle, only medical corporations without equity could be newly established. The aim of this reform was to clarify the non-profit nature of medical corporations and prevent them from becoming private assets.
In a medical corporation with equity, contributors (members) hold the right to demand a refund of their contributed amount upon withdrawal or the distribution of residual assets upon dissolution. Because this equity interest is subject to inheritance and gift taxes, it carries the substantial risk of triggering heavy tax burdens during business succession.
Conversely, a medical corporation without equity is structured either by waiving equity interests upon incorporation or by adopting the foundation fund (kikin) system. Under the fund system, contributions from founders or members are received as a “fund” and used as operating capital for the medical corporation. While the fund may be returned to contributors under specific conditions defined in the Articles of Incorporation (for example, upon dissolution), unlike equity shares, the corporation’s assets do not belong to individual owners in principle. Consequently, a major feature is that it is not subject to inheritance or gift tax.
Transitioning from an equity-holding medical corporation to one without equity has gained significant attention as an essential path for existing corporations to align with this modern framework and facilitate smooth succession in the future.
| Item | Medical Corporation With Equity | Medical Corporation Without Equity (Fund Type) |
|---|---|---|
| Equity Interest (Ownership) | Present (right to demand refund / distribution of residual assets) | None (no inherent obligation to refund contributors) |
| Tax Burden during Succession | Subject to inheritance tax and gift tax | In principle, exempt from inheritance tax and gift tax |
| Establishment Period | Predominantly established on or before March 31, 2007 | Established on or after April 1, 2007, or transitioned thereafter |
| Public Interest / Non-Profit Nature | For-profit nature is sometimes questioned | Non-profit nature is clearly established |
Benefits of Transitioning to a Medical Corporation Without Equity
Transitioning from an equity-holding medical corporation to a non-equity structure provides numerous advantages, particularly when planning for business succession. The most prominent benefit lies in the tax advantages.
Key Advantages
- Avoidance or Mitigation of Inheritance and Gift Taxes: Because the transition eliminates ownership equity, the substantial inheritance or gift taxes otherwise levied on the successor can be avoided or dramatically reduced. This is a crucial factor in securing the permanent continuity of healthcare institutions.
- Facilitation of Business Succession: Removing concerns over heavy tax burdens makes options beyond family succession—such as third-party M&A or succession to executive staff—far more viable. The flexibility of succession planning increases, enabling the selection of the most suitable successor.
- Enhanced Attractiveness in M&A: From an acquirer’s perspective, a medical corporation without equity carries fewer operational and tax risks post-acquisition, making it a much more attractive target. This significantly broadens potential M&A opportunities.
- Clearer Asset Separation under Fund System: Although the fund system allows reimbursement to contributors only under conditions stipulated in the Articles of Incorporation, it is not evaluated as personal wealth in the same way equity is. This prevents the corporation’s assets from being treated as personal property and reinforces non-profit integrity.
These advantages enhance the sustainability of healthcare institutions and significantly contribute to future managerial stability. In particular, mitigating the risk that an essential medical facility serving regional healthcare could be forced to shut down due to succession problems holds substantial social significance.
Disadvantages and Key Considerations of the Transition
While transitioning to a non-equity medical corporation offers significant benefits, it also presents several disadvantages and points of caution. It is critical to thoroughly understand these factors and formulate countermeasures.
First is the complexity of the transition procedures. Approval from the prefectural governor is required, entailing a wide range of specialized procedures such as amending the Articles of Incorporation, asset valuations, and explanatory briefings to relevant stakeholders. These steps demand substantial time, effort, and specialized expertise.
Second is tax risk. When equity interests are waived, the tax authority may determine this to be a “deemed gift” (minashi zoyo), potentially triggering gift tax liabilities for the individual waiving the equity. This risk is particularly pronounced in corporations with high equity valuation. Furthermore, if the waived equity is absorbed by the corporation, it may be recognized as donation income (gain on assets received), giving rise to corporate tax liabilities. These tax treatments are exceedingly intricate, making meticulous advance simulations and expert advice indispensable.
Third is the restriction on fund refunds. Funds cannot, in principle, be returned except under the specific conditions defined in the Articles of Incorporation. Consequently, even if founders or contributors wish to recover their capital in the future, their liquidity is severely restricted. While this is essential for separating personal and corporate assets, contributors may perceive it as a disadvantage.
Additionally, constraints on member succession and continuity of licenses and permits must be considered. Even after transitioning to a non-equity corporation, governance remains in the hands of the General Meeting of Members. Provisions in the Articles of Incorporation regarding member composition and changes will impact future leadership structures. Furthermore, the transition may require re-verification of various administrative licenses and facility standards, necessitating advance coordination with regulatory authorities. Compliance with medical fee revisions and regional healthcare visions must also be accounted for.
To minimize these disadvantages and risks, it is imperative to partner with trusted M&A/succession specialists and licensed tax accountants to develop a transition plan from a comprehensive perspective.
Step-by-Step Transition Process and Key Points
Transitioning from an equity-holding medical corporation to a non-equity structure is a complex process requiring expert knowledge. Below are the key steps in the standard transition process, along with crucial points for each phase:
- Status Analysis and Decision to Transition:
Conduct a thorough review of the medical corporation’s financial standing, asset portfolio, equity valuation, the intentions of the board president and members, and the presence of successor candidates. Fully understand the pros and cons, and secure consensus among all stakeholders. Commencing consultations with specialists (tax accountants, legal counsel, M&A advisors) at this stage is highly recommended.
- Equity Valuation and Tax Simulation:
The valuation of equity heavily impacts transition tax outcomes (especially deemed gifts). Retain a certified public accountant or tax accountant to derive an objective valuation. Based on this value, run simulations of tax liabilities (gift tax, corporate tax, etc.) to determine the optimal timing and method.
- Drafting Amended Articles of Incorporation and Approval by the General Meeting of Members:
Draft amended Articles of Incorporation to waive ownership equity and adopt the fund system. The proposed amendments must be officially approved at a General Meeting of Members. Thorough explanations and consensus-building among members are essential.
- Application for Prefectural Governor Approval:
Following approval of the amendments, apply for authorization to transition to a non-equity medical corporation with the relevant prefectural governor. The application requires extensive documentation, including the amended Articles of Incorporation, business plans, asset inventories, and director rosters. Because approval can take several months, sufficient lead time must be scheduled.
- Commercial Registration Changes and Tax Office Filings:
Once authorization is granted, file the change of registration with the Legal Affairs Bureau. Additionally, submit the prescribed notification forms to the tax office and prefectural tax office to notify them of the structural change.
- Re-verification of Licenses and Facility Standards:
To ensure uninterrupted clinic/hospital operations after the transition, confirm the continuity of necessary healthcare licenses and facility standards with public health centers and regulatory authorities. In some instances, new notifications or approvals may be required.
Because these steps are interrelated, a single deficiency can derail the transition schedule. Close coordination with professionals and methodical execution are key to success.
Tax Treatments and Countermeasures During Transition
Taxation in transitioning to a non-equity medical corporation requires the deepest level of specialized knowledge. In particular, understanding and preparing for “deemed gifts” and “taxation on gains from donated assets” is critical.
1. Taxation Arising from Equity Waiver (Deemed Gift):
When an equity-holding medical corporation transitions to a non-equity entity, existing equity interests are extinguished. Tax authorities may deem this waiver an economic benefit transferred from the individual contributor to the corporation, potentially levying gift tax on the contributor. The taxable amount corresponds to the fair market value of the equity interest at the time of the waiver. Countermeasures include precise advance valuation, prior consultations with the tax office, and leveraging the Certified Medical Corporation (Nintei Iryo Hojin) special relief scheme.
2. Corporate Tax on Donation Gains (Receipt of Profit):
When an individual waives their equity and the underlying assets revert to the corporation, the entity may recognize taxable profit (gain from donated assets), giving rise to corporate tax. However, special non-taxable exceptions exist if specific statutory requirements are met. Professional review ahead of time is vital.
3. Treatment of Enterprise Tax:
Medical corporations are subject to enterprise tax. While transitioning to a non-equity corporation does not change this baseline treatment, transitioning to highly public-interest corporate forms (such as a social medical corporation / shakai iryo hojin) may qualify the entity for enterprise tax reductions. The relationship between the post-transition corporate status and enterprise tax should be evaluated in advance.
4. Character and Taxation of Funds:
Unlike equity contributions, funds are generally not treated as taxable valuation assets. However, if the Articles of Incorporation specify terms for refunding the fund, the tax treatment may become complex depending on the conditions and amounts involved. The tax implications for contributors must be evaluated on a case-by-case basis.
These tax considerations vary significantly depending on the corporation’s scale, financial structure, and equity appraisal. Misjudgments can lead to substantial additional tax assessments; thus, collaborating with tax advisors and attorneys well-versed in medical M&A and succession is crucial. Accurate risk assessments and proper measures will ensure a smooth transition and optimal tax outcomes.
The Regional Medical Care Vision and the Future of Non-Equity Medical Corporations
Japan’s healthcare sector is grappling with an aging population, declining birthrates, and mounting medical expenditures. In response, the government is driving the “Regional Medical Care Vision.” This initiative aims to optimize regional medical demand and bed functions, calling on healthcare institutions to achieve greater public interest and operational efficiency.
In this environment, medical corporations without equity occupy an advantageous position to fulfill their mandate under the Regional Medical Care Vision due to their clear non-profit nature and high degree of public accountability. They are well-positioned to respond flexibly to local healthcare demands, such as bed function realignment, enhanced community coordination, and expansion into home-based healthcare.
Furthermore, ongoing medical fee schedule revisions and tightening of facility standards continuously impact healthcare management. Because assets in a non-equity medical corporation are shielded from privatization, operating profits can be reinvested directly into clinic upgrades, advanced medical equipment, and staff development, strengthening high-quality care delivery. This reinvestment capability enables institutions to respond with greater agility to future statutory fee revisions and standards.
Moreover, as medical institution M&A and regional consolidation accelerate, non-equity medical corporations are increasingly viewed as attractive acquisition targets due to the absence of equity-related tax complications. From the standpoint of preserving indispensable community healthcare infrastructure, this corporate stability is a paramount advantage.
The Regional Medical Care Vision presents new challenges to healthcare organizations, and transitioning to a medical corporation without equity offers a strategic solution to meet these shifts and maintain community care into the future. Executives should evaluate this transition not merely as a tax measure, but as a strategic commitment aligned with their long-term vision and regional healthcare contribution.
Transitioning to a medical corporation without equity is a consequential management decision. The process demands cross-disciplinary expertise spanning healthcare law, taxation, and organizational governance, accompanied by a strategic approach grounded in the nuances of the medical industry. At M&A Medical, our consultants possess extensive experience and specialized know-how in healthcare succession and M&A, providing end-to-end guidance from tailored transition planning to final execution. Contact us today for a free consultation to discuss your institution’s specific challenges and questions.
Consult M&A Medical for Healthcare Business Succession
M&A Medical is a specialized advisory service dedicated to M&A and business succession for healthcare institutions. As an M&A Support Agency certified by the Small and Medium Enterprise Agency, we support clinic and medical corporation transfers facing successor shortages as well as strategic acquisitions on a contingency fee basis.
- Initial consultation and preliminary valuation are free
- No upfront retainer or monthly retainer fees (100% success fee basis)
- Strict confidentiality guaranteed (executed under NDA)
- Serving all 47 prefectures and all medical specialties across Japan
Whether you want to assess market valuation, lack a successor, or are exploring joining a hospital/clinic group, we encourage you to consult us at the earliest stage of your consideration.